Elicio Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ELTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
451 D Street, 5 Th Floor, Boston, MA

Insiders trading volume in the past year

Elicio Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Yekaterina Chudnovsky Director, 10%+ Owner $34M +$41M Aug 12, 2024
Eisa Abc Llc 10%+ Owner $15.9M Aug 31, 2021
Itzhak Goldberg Director $9.81M Jul 1, 2022
Jay Venkatesan Director $499K +$998K Jun 28, 2024
Victor F. Ganzi Director $87.2K Jun 9, 2022
Gilbert S. Omenn Director $87.2K Jun 9, 2022
Jennifer J. Rhodes Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Secretary Mar 2, 2022
John F. Neylan Executive Vice President, Chief Medical Officer and Head of Research Mar 2, 2022
Gregory S. Curhan Chief Financial Officer Mar 2, 2022
Carol Ashe Director Dec 28, 2023
Allen Nissenson Director Dec 28, 2023
Assaf Segal Director Jun 1, 2023
Robert R. Ruffolo Director Dec 28, 2023
Karen J. Wilson Director Dec 28, 2023
Christopher Haqq Title: Executive Vice President, Head of R&D and Chief Medical Officer Sep 30, 2024
Julian Adams Director Dec 28, 2023
Brian Piekos Chief Financial Officer Feb 1, 2024
Robert Connelly CEO, President and Director, Director Sep 30, 2024
Annette Matthies Chief Business Officer Jun 1, 2023
Peter DeMuth Chief Scientific Officer Sep 30, 2024

Recent Insider Transactions by Companies or Individuals for Elicio Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.